TGF-β, a crucial cytokine for fostering immunosuppression in the tumor microenvironment derived from platelets, reduces natural killer group 2D (NKG2D) receptor expression and inhibits their antitumor reactivity [239]. This evidence concerns the gene TGFB1 and neoplasm.